LCID
Lucid Group, Inc.
LCID has the edge over LGIH overall, supported by stronger valuation and stronger fundamentals.
LGIH
LGI Homes, Inc.
LGIH has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LGIH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
LGIH's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
LGIH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $20.61 | -50% |
| Fair | 11x | $33.17 | -19% |
| Expensive | 14x | $42.66 | +3.7% |
| Current | 14x | $41.12 | — |
| Forward | 15x | $41.12 | — |
Historical ranges are pointers, not guarantees.
LGIH's PE is in its expensive range at 14x. On analysts' estimates for next year's earnings, today's price would be 15x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LGIH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect LGIH's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
LGIH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.67 | -12% |
| Q3 2026 | $3.04 | -33% |
| Q2 2026 | $2.84 | -57% |
| Q1 2026 | $3.04 | -61% |
| Q4 2025 | $3.12 | -62% |
| Q3 2025 | $4.53 | -46% |
| Q2 2025 | $6.63 | -19% |
| Q1 2025 | $7.75 | -3.1% |
| Q4 2024 | $8.30 | -1.4% |
LGIH has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over LGIH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
LGIH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $444.5M | +12% |
| Q2 2026 | $516M | +6.7% |
| Q1 2026 | $319.7M | -9% |
| Q4 2025 | $474M | -15% |
| Q3 2025 | $396.6M | -39% |
| Q2 2025 | $483.5M | -20% |
| Q1 2025 | $351.4M | -10% |
| Q4 2024 | $557.4M | -8.4% |
LGIH's revenue is recovering but still below its 2020 peak: $444M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.5% | +2.1 points |
| Q2 2026 | 7.1% | -1.1 points |
| Q1 2026 | -0.2% | -0.2 points |
| Q4 2025 | 3.9% | -4.3 points |
| Q3 2025 | 5.4% | -6.9 points |
| Q2 2025 | 8.2% | -3 points |
| Q1 2025 | 0.1% | -4.7 points |
| Q4 2024 | 8.2% | -1.7 points |
LGIH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
LGIH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.9M | +$51.2M |
| Q2 2026 | $113.7M | +$200.2M |
| Q1 2026 | -$56.2M | +$71.7M |
| Q4 2025 | $86.8M | +54% |
| Q3 2025 | -$13.3M | +$4.6M |
| Q2 2025 | -$86.4M | -$2.7M |
| Q1 2025 | -$128M | -$27.5M |
| Q4 2024 | $56.4M | +$90.7M |
LGIH has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
LGIH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +187K shares |
| 1 year | +1.4% | +317K shares |
| 3 years | -0.7% | -175K shares |
| 5 years | -5.5% | -1.4M shares |
| Available history | -7.7% | -2M shares |
LGIH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $20.6M |
| Q1 2025 | $3.1M |
| Q4 2024 | $13M |
| Q3 2024 | — |
| Q2 2024 | $8M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LGIH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | 19.0x | High |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 6.6x | High |
LGIH has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LGIH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 20.0 | Oversold |
LGIH's weekly RSI is 38 (neutral) and its Stochastic is 20 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
LGIH PE vs Consumer Cyclical Sector
| Metric | LGIH | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 25% below |
| PE % | 80 | 47 | 33 pts above |
LGIH is trading at 14x earnings, a 25% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
LGIH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.8 | 8.2% below |
| 20 week MA | $52.1 | 21% below |
| 50 week MA | $49.7 | 17% below |
| 100 week MA | $56.1 | 27% below |
| 200 week MA | $83.9 | 51% below |
LGIH is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
LGIH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $70.5 | $112.7 | +60% |
| 2021 | $112.7 | $152.2 | +35% |
| 2022 | $152.2 | $94.8 | -38% |
| 2023 | $94.8 | $133.2 | +40% |
| 2024 | $133.2 | $89.6 | -33% |
| 2025 | $89.6 | $43.2 | -52% |
| 2026 YTD | $43.2 | $41.1 | -4.8% |
LGIH has the edge over LCID on returns for 2026, with the stronger performance.